KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
17,562
Total Value
$88,730.62
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 11, 2026 | Exercise/Conversion | 7,120 | โ | โ | 469,697 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 3,322 | $26.71 | $88,730.62 | 466,375 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | May 11, 2026 | Exercise/Conversion | 7,120 | $0.00 | $0.00 | 92,560 | Direct | โ | View Details |